XML 44 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
FAIR VALUE MEASUREMENT (Tables)
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON RECURRING BASIS
The following tables present information about the Company’s assets measured at fair value on a recurring basis and the Company’s estimated level within the fair value hierarchy for each of those assets and liabilities as of March 31, 2024 and December 31, 2023, respectively:

Recurring fair value measured at March 31, 2024
(in thousands)Total carrying valueQuoted prices in active markets
(Level 1)
Significant other observable inputs
(Level 2)
Significant unobservable inputs
(Level 3)
Assets:
Money market funds$117,186 $117,186 $— $— 
Digital assets1,234,695 1,234,695 — — 
Liabilities:
Derivative instrument (1)
4,263 — 4,263 — 
Contingent consideration liability (2)
3,523 — — 3,523 
 
Recurring fair value measured at December 31, 2023
(in thousands)Total carrying valueQuoted prices in active markets
(Level 1)
Significant other observable inputs
(Level 2)
Significant unobservable inputs
(Level 3)
Assets:
Money market funds$141,147 $141,147 $— $— 
U.S. Treasury Bills60,541 60,541 — — 
Digital assets639,660 639,660 — — 

(1) Refer to Note 2 - Summary of Significant Accounting Policies - Derivatives, for further information.

(2) Represents the estimated amount of acquisition-related consideration expected to be paid in the future as of March 31, 2024. Refer to Note 3 – Acquisitions, for further information.
SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON NON-RECURRING BASIS
The following tables present information about the Company’s liabilities measured at fair value on a non-recurring basis and are, therefore, not included in the tables above. These liabilities include outstanding convertible notes measured at fair value based on quoted prices in active markets. These liabilities are not measured at fair value on an ongoing basis but are subject to fair value adjustments in certain circumstances (e.g., impairment). The Company’s estimated level within the fair value hierarchy for each of these liabilities as of March 31, 2024 and December 31, 2023, respectively, is as follows:

Non-recurring fair value measured at March 31, 2024
(in thousands)Total carrying valueQuoted prices in active markets
(Level 1)
Significant other observable inputs
(Level 2)
Significant unobservable inputs
(Level 3)
Liabilities:
Notes payable
$326,083 $277,774 $— $— 

Non-recurring fair value measured at December 31, 2023
(in thousands)Total carrying valueQuoted prices in active markets
(Level 1)
Significant other observable inputs
(Level 2)
Significant unobservable inputs
(Level 3)
Liabilities:
Notes payable
$325,654 $269,725 $— $—